OrSense Alternatives & Competitors
12 companies similar to OrSense
Companies similar to OrSense
Finapres Medical Systems
The leading technology for continuous non-invasive blood pressure measurement, autonomic t...
Know Labs, Inc.
Transforming Non-Invasive Medical Diagnostics
SunTech
Clinical-Grade Non-Invasive Blood Pressure Technology and Medical Devices
HME Square
We listen to your glucose.
Track all OrSense competitors
Get real-time alerts when any of these companies raise funding, hire, or show growth signals.
Cercacor
Empower Your Body, Enhance Your Life
BMEYE
Pioneering non-invasive cardiovascular monitoring with advanced finger arterial pressure a...
Sensydia Corporation
Advancing cardiovascular care with non-invasive, point-of-care hemodynamic measurement.
PyrAmes
Blood pressure monitoring reimagined
Leuko
Non-invasive white blood cell monitoring
SanguisAI
Diagnosing anaemia; non-invasively, inexpensively, and fast.
Nourica
Non-invasive health biomarkers diagnostics from human sweat
Biobeat
AI remote patient monitoring platform, measuring 13 vital signs and triggering early clini...
About OrSense
OrSense is a medical device company founded in 1997 and headquartered in Israel. The company is focused on developing and marketing non-invasive monitoring systems for the measurement of Hemoglobin. OrSense's flagship product, the NBM200 system, has been successfully installed in dozens of blood donation facilities wor...
Non-invasive Monitoring, Hemoglobin Measurement, Blood Donation, Occlusion Spectroscopy Technology
Frequently Asked Questions
Don't just read about them. Follow them.
BounceWatch watches OrSense and millions of other companies. When one raises money, hires quickly or changes its product, we tell you the same day.
Compiled from the BounceWatch company index. We last looked at OrSense on 12 Sep 2024. The 12 companies listed here were last checked between 11 Sep 2024 and 6 Aug 2026. Where a field is blank here, it means we have not recorded it — not that the answer is zero. How we source and date this.